Giant cell arteritis: immune and vascular aging as disease risk factors
- PMID: 21861860
- PMCID: PMC3239337
- DOI: 10.1186/ar3358
Giant cell arteritis: immune and vascular aging as disease risk factors
Abstract
Susceptibility for giant cell arteritis increases with chronological age, in parallel with age-related restructuring of the immune system and age-induced remodeling of the vascular wall. Immunosenescence results in shrinkage of the naïve T-cell pool, contraction of T-cell diversity, and impairment of innate immunity. Aging of immunocompetent cells forces the host to take alternative routes for protective immunity and confers risk for pathogenic immunity that causes chronic inflammatory tissue damage. Dwindling immunocompetence is particularly relevant as the aging host is forced to cope with an ever growing infectious load. Immunosenescence coincides with vascular aging during which the arterial wall undergoes dramatic structural changes and medium and large arteries lose their pliability and elasticity. On the molecular level, elastic fibers deteriorate and matrix proteins accumulate biochemical modifications. Thus, the aging process impacts the two major biologic systems that liaise to promote giant cell arteritis; the immune system and the vessel wall niche.
Figures



Similar articles
-
The immunoinhibitory PD-1/PD-L1 pathway in inflammatory blood vessel disease.J Leukoc Biol. 2018 Mar;103(3):565-575. doi: 10.1189/jlb.3MA0717-283. Epub 2017 Dec 29. J Leukoc Biol. 2018. PMID: 28848042 Free PMC article. Review.
-
Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.Circulation. 2018 May 1;137(18):1934-1948. doi: 10.1161/CIRCULATIONAHA.117.030423. Epub 2017 Dec 18. Circulation. 2018. PMID: 29254929 Free PMC article.
-
Vascular damage in giant cell arteritis.Autoimmunity. 2009 Nov;42(7):596-604. doi: 10.1080/08916930903002495. Autoimmunity. 2009. PMID: 19657775 Free PMC article. Review.
-
[Pathophysiology of giant cell arteritis].Rev Med Interne. 2013 Jul;34(7):392-402. doi: 10.1016/j.revmed.2013.02.037. Epub 2013 Mar 23. Rev Med Interne. 2013. PMID: 23528439 Review. French.
-
Cellular Signaling Pathways in Medium and Large Vessel Vasculitis.Front Immunol. 2020 Sep 25;11:587089. doi: 10.3389/fimmu.2020.587089. eCollection 2020. Front Immunol. 2020. PMID: 33072134 Free PMC article. Review.
Cited by
-
Chronic inflammation and aging: DNA damage tips the balance.Curr Opin Immunol. 2012 Aug;24(4):488-93. doi: 10.1016/j.coi.2012.04.003. Epub 2012 May 5. Curr Opin Immunol. 2012. PMID: 22565047 Free PMC article. Review.
-
Systematic Review of the Yield of Temporal Artery Biopsy for Suspected Giant Cell Arteritis.Neuroophthalmology. 2018 Jun 19;43(1):18-25. doi: 10.1080/01658107.2018.1474372. eCollection 2019 Feb. Neuroophthalmology. 2018. PMID: 30723520 Free PMC article. Review.
-
CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells.J Immunol. 2012 Sep 1;189(5):2118-30. doi: 10.4049/jimmunol.1200122. Epub 2012 Jul 20. J Immunol. 2012. PMID: 22821963 Free PMC article.
-
Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA.Front Immunol. 2019 Jul 16;10:1638. doi: 10.3389/fimmu.2019.01638. eCollection 2019. Front Immunol. 2019. PMID: 31379838 Free PMC article.
-
Does low risk of infections as a marker of effective immunity predict increased risk of subsequent giant cell arteritis or polymyalgia rheumatica? A Danish population-based case-control study.Clin Epidemiol. 2018 Oct 16;10:1533-1543. doi: 10.2147/CLEP.S158293. eCollection 2018. Clin Epidemiol. 2018. PMID: 30425584 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical